Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor - Video

In this video, Dr. Akhil Kapoor, Medical Oncologist at Tata Memorial Centre, Varanasi, Uttar Pradesh, discusses a real-world case study of chemotherapy-induced anemia in advanced breast cancer. The case features a 63-year-old woman diagnosed with HER2-positive metastatic breast cancer, who was started on standard chemotherapy with paclitaxel, trastuzumab, and pertuzumab. While chemotherapy is widely used for cancer, it often leads to side effects such as anemia, which can severely impact a patient’s quality of life.

Dr. Kapoor highlights how darbepoetin alfa, an erythropoiesis-stimulating agent, played a crucial role in managing her chemotherapy-induced anemia by improving hemoglobin levels. Watch the full video to gain clinical insights into the use of darbepoetin alfa in breast cancer management and its role in improving patient outcomes in real-world oncology practice.